Literature DB >> 22329716

Predictors of early and mid-term results in contemporary aortic valve replacement for aortic stenosis.

Kenji Kuwaki1, Atsushi Amano, Hirotaka Inaba, Taira Yamamoto, Takeshi Matsumura, Shizuyuki Dohi, Satoshi Matsushita.   

Abstract

BACKGROUND: The purpose of this study was to evaluate clinical risk factors and assess the impact of the Society of Thoracic Surgeons (STS) scores on outcomes after contemporary aortic valve replacement (AVR) for aortic stenosis (AS).
METHODS: We retrospectively analyzed the data from 209 consecutive patients with AS (mean 69 ± 9 years) who underwent AVR. The outcomes measured included operative mortality, postoperative complications, postoperative prolonged length of stay (PLOS), discharge to nonhome location, and mid-term mortality.
RESULTS: Operative mortality was 3.8%, and five-year survival was 88.6 ± 2.8%. Multivariable analysis revealed preoperative New York Heart Association (NYHA) class as a significant predictor of both operative mortality (p = 0.03; odds ratio [OR]: 8.5) and mid-term mortality (p = 0.02; OR: 10.5). NYHA class also emerged as an independent predictor for postoperative complications (p = 0.002; OR: 5.8) and PLOS (p = 0.01; OR: 2.5). Other preoperative independent predictors included dialysis for PLOS (p = 0.04; OR: 2.9), age (p = 0.03; OR: 1.1), and left ventricular ejection fraction (EF; p = 0.03; OR: 0.9) for nonhome discharge, and EF for mid-term mortality (p = 0.01; OR: 0.9). The mean STS-PROM (predicted risk of mortality) was 4.6% ± 6.1%, and thus, the observed-to-expected (O/E) ratio of operative mortality in our series was 0.82.
CONCLUSIONS: Advanced NYHA class, older age, dialysis, and lower EF are significant independent preoperative risk factors for early and mid-term results of AVR for AS. Consideration of these predictors should be used to identify high-risk patients requiring AVR for AS.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22329716     DOI: 10.1111/j.1540-8191.2011.01398.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  4 in total

1.  Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery.

Authors:  Lindsey L Saint; Ralph J Damiano; Phillip S Cuculich; Tracey J Guthrie; Marc R Moon; Nabil A Munfakh; Hersh S Maniar
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08-30       Impact factor: 5.209

2.  Type of Valvular Heart Disease Requiring Surgery in the 21st Century: Mortality and Length-of-Stay Related to Surgery.

Authors:  Konstantinos Dean Boudoulas; Yazhini Ravi; Daniel Garcia; Uksha Saini; Gbemiga G Sofowora; Richard J Gumina; Chittoor B Sai-Sudhakar
Journal:  Open Cardiovasc Med J       Date:  2013-09-04

3.  Predictors of Mortality and Symptomatic Outcome of Patients With Low-Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Norman Mangner; Georg Stachel; Felix Woitek; Stephan Haussig; Florian Schlotter; Robert Höllriegel; Jennifer Adam; Anna Lindner; Friedrich W Mohr; Gerhard Schuler; Philipp Kiefer; Sergey Leontyev; Michael A Borger; Holger Thiele; David Holzhey; Axel Linke
Journal:  J Am Heart Assoc       Date:  2018-04-13       Impact factor: 5.501

4.  Aortic stiffness as a marker of cardiac function and myocardial strain in patients undergoing aortic valve replacement.

Authors:  Emaddin Kidher; Leanne Harling; Hutan Ashrafian; Hatam Naase; Darrel P Francis; Paul Evans; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2014-06-17       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.